...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Tumori. >Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy
【24h】

Hepatocellular carcinoma with peritoneal metastasis treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy

机译：减瘤术加腹膜热化疗联合治疗肝癌腹膜转移

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Peritoneal carcinomatosis from hepatocellular carcinoma is well regarded as a poorly treatable malignant disease with rapid decline. Over the past decade, new modalities that combine cytoreductive surgery with perioperative hyperthermic intraperitoneal chemotherapy have been shown to be aggressive local-regional treatments with improved survival. We present a case of a 67-year-old non-cirrhotic woman with peritoneal metastases from hepatocellular caracinoma who was treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy. Consideration remains individualized, but it can be considered in patients with adequate preservation of liver function, management of their primary hepatocellular caracinoma as well as the localized nature of their peritoneal metastases.
机译：肝细胞癌引起的腹膜癌病被认为是一种恶性疾病，治疗迅速，下降迅速。在过去的十年中，将细胞减少术与围手术期高温腹膜内化疗相结合的新方法已被证明是积极的局部治疗，可提高生存率。我们提出了一例67岁的非肝硬化妇女，其发生了肝细胞癌的腹膜转移，并接受了细胞减灭术加腹膜热化疗。考虑因素仍然是个体化的，但是可以在肝功能得到充分保护，原发性肝细胞癌的治疗以及腹膜转移的局部性的患者中考虑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号